Physician profile
Jesse M Thon
NPI 1356789747
$3,883.88
in general payments reported to CMS, 2019-2025
20 companies · $274 in 2025
The $274 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $593 · 2020: $168 · 2021: $1,629 · 2022: $448 · 2023: $227 · 2024: $546 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,046.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,046.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $1,155.58 | 2020-2021 | |
| Amgen INC. | $611.84 | 2024-2025 | Uplizna |
| Genentech USA, INC. | $256.16 | 2019-2025 | Ocrevus Zunovo |
| E.R. Squibb & Sons, L.L.C. | $200.95 | 2021-2022 | |
| Horizon Therapeutics Plc | $198.83 | 2022-2023 | Uplizna |
| Biohaven Pharmaceuticals, INC. | $177.05 | 2021 | |
| Boston Scientific Corporation | $153.19 | 2019 | |
| Philips North America LLC | $142.48 | 2022-2024 | (5044) Mcot |
| Janssen Pharmaceuticals, INC | $140.08 | 2022 | |
| Greenwich Biosciences, INC. | $133.39 | 2019 | |
| Celgene Corporation | $126.21 | 2021 | |
| Tg Therapeutics, INC. | $115.67 | 2024 | |
| Portola Pharmaceuticals, LLC | $110.19 | 2020 | |
| Sk Life Science, INC. | $104.16 | 2023 | Xcopri |
| Eisai INC. | $82.06 | 2019-2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $81.79 | 2019-2021 | |
| Medtronic, INC. | $41.50 | 2021-2022 | |
| Impel Pharmaceuticals INC. | $24.46 | 2022 | |
| Avanir Pharmaceuticals, INC. | $14.71 | 2019 | |
| W. L. Gore & Associates, INC. | $13.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Thon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.